BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026

  June 30, 2026

   · 

  6 min read
• Press Releases

  Biovica International AB - Annual Report for The Financial Year 2025/2026 Published

  June 30, 2026

   · 

  1 min read
• Press Releases

  WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy

  June 30, 2026

   · 

  4 min read
• Press Releases

  OTR4132 in patients with ischemic stroke meets primary efficacy endpoint

  June 30, 2026

   · 

  1 min read
• Press Releases

  Zerion Pharma completes royalty financing and equity investment transaction with Ligand to advance the Dispersome® technology

  June 30, 2026

   · 

  1 min read
• Press Releases

  Zelluna ASA awarded NOK 16 million Research Council of Norway grant

  June 30, 2026

   · 

  1 min read
• Press Releases

  HUTCHMED to Announce 2026 Half-Year Financial Results

  June 30, 2026

   · 

  1 min read
• Press Releases

  AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans

  Phase I results provide platform-level validation supporting AdJane’s broader development programs in pandemic preparedness, respiratory infectious diseases and antimicrobial resistance

  June 30, 2026

   · 

  1 min read
• Press Releases

  Exonate appoints Olav Hellebø as Chief Executive Officer

  June 30, 2026

   · 

  2 min read
• Press Releases

  Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

  June 30, 2026

   · 

  4 min read